NASDAQ$CLMT
Calumet Inc · Q1 2025 earnings
Q1 2025 earnings · · Investor relations
Briefing
Calumet reported Q1 2025 sales of $993.9M with a net loss of $162.0M and diluted EPS of $(1.87).
Sales were $993.9 million while the company posted a net loss of $162.0 million, including debt extinguishment and derivative impacts. Diluted EPS was $(1.87). Specialty products and renewable fuels investments remain strategic.
- Q1 sales $993.9M.
- Net loss $162.0M; diluted EPS $(1.87).
- Specialty chemicals and fuels margin environment.
- Refinancing and hedging costs affected other expense.
Headline financials
Revenue & EPS history
Calumet Specialty Products · Revenue · Quarterly
$994M
Forward guidance
Industrial outlook reflects construction, ag cycles, and interest-rate sensitivity.
Tailwinds
- Productivity and mix shift to higher-margin lines.
- Long-term infrastructure and conversion opportunities.
Headwinds
- Volume softness in cyclical end markets.
- Weather, rates, and input costs.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 5 quarterly earnings reports · overlaid with Q1 2025
-4.3%
Avg return
Earnings day
-2.3%
Avg return
5 days after
+6.6%
Avg return
30 days after
17%
1 / 6 earnings
Positive
+6.5%
Q1 2025
Best reaction
-10.8%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -7.4% | -9.3% | +1.5% | |
| Q4 2025 | -10.8% | -3.0% | +6.1% | |
| Q3 2025 | -1.6% | -3.0% | -0.9% | |
| Q2 2025 | -3.6% | -4.2% | +19.7% | |
| Q1 2025 | +6.5% | +11.4% | +14.9% | |
| Q3 2024 | -8.6% | -6.0% | -1.9% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro